Clinical trials for anal cancer

24 currently recruiting clinical trials
Anal cancer

Phase 3 Anal cancer
#NCT06207981
Locally Advanced
Radiotherapy Radiotherapy
CHU - Haut-Lévêque - Bordeaux (Pessac), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Hôpital Privé Sainte Marie - Ramsay Santé (Chalon-sur-Saône), Institut de Cancérologie des Hauts-de-France - Centre Marie Curie (Arras), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon) (and 1 more...)
Fédération Francophone de Cancérologie Digestive
Phase 2 Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Stomach and esophageal cancer
#NCT05325866
Adenocarcinoma Metastatic Metastatic Castration-resistant FGFR 1 2 3 or more
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 3 more...)
Amgen
Phase 2
#NCT02628067
Locally Advanced Metastatic Metastatic Castration-resistant MSI/dMMR 1 2 3 or more
Immunotherapy Systemic Treatment-Naive Immunotherapy
Centre Léon Bérard (Lyon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Besançon (Besançon), IUCT Oncopôle (Toulouse), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain) (and 4 more...)
Merck Sharp & Dohme LLC
Phase 2
#NCT02628067
Locally Advanced Metastatic Metastatic Castration-resistant 1 2 3 or more
MSI/dMMR Immunotherapy Systemic Treatment-Naive Immunotherapy
Gustave Roussy (Villejuif), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 4 more...)
Merck Sharp & Dohme LLC
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer
#NCT05751798
Locally Advanced Metastatic Metastatic Castration-resistant MSI/dMMR PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 3 or more
Systemic Treatment-Naive Immunotherapy Systemic Treatment-Naive Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
#NCT05503797
Locally Advanced Metastatic BRAF 1 2 3 or more
HRAS KRAS G12C KRAS non G12C NRAS Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 2 more...)
Fore Biotherapeutics
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer
#NCT05503797
Neuroendocrine tumor Locally Advanced Metastatic BRAF 1 2 3 or more
HRAS KRAS G12C KRAS non G12C NRAS Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 2 more...)
Fore Biotherapeutics
Phase 2 Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux) (and 2 more...)
PMV Pharmaceuticals, Inc
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Endometrial cancer
#NCT06760819
Clear cell carcinoma Stomach Oesogastric junction Esophagus Adenocarcinoma Other Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Ampullary carcinoma Gastrointestinal stromal tumor Squamous cell carcinoma HER2 Positive Locally Advanced Metastatic Metastatic Castration-resistant HER2 1
Systemic Treatment-Naive
Centre Oscar Lambret (Lille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut Bergonié (Bordeaux)
Bayer
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer
#NCT06475352
Locally Advanced Metastatic None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Centre Hospitalier de la Côte Basque (Bayonne) (and 28 more...)
UNICANCER